Over the past 12 months, 10 insiders at CORCEPT THERAPEUTICS INC filed 84 open-market SEC Form 4 transactions on CORT: 2 purchases worth $3.3M and 82 sales worth $69.6M. Insiders have been net sellers over this period. The most recent filing was on Jul 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 26 | Atabak MokariChief Financial Officer | SELL | 28.5K | $89.43 | $2.5M |
| Jul 15, 26 | James N WilsonDirector | SELL | 4.0K | $89.49 | $348K |
| Jul 7, 26 | William GuyerChief Development Officer | SELL | 19.0K | $93.54 | $1.8M |
| Jul 1, 26 | Sean MaduckSee Remarks | SELL | 11.2K | $89.31 | $998K |
| Jun 17, 26 | David L Mahoney | SELL | 20.0K | $84.53 | $1.7M |
| Jun 16, 26 | James N Wilson | SELL | 5.8K | $83.57 | $487K |
| Jun 15, 26 | Atabak MokariChief Financial Officer | SELL | 19.5K | $81.81 | $1.6M |
| Jun 2, 26 | William GuyerChief Development Officer | SELL | 20.0K | $70.60 | $1.4M |
| Jun 1, 26 | Sean MaduckSee Remarks | SELL | 21.1K | $70.75 | $1.5M |
| Jun 1, 26 | Atabak MokariChief Financial Officer | SELL | 40.0K | $70.00 | $2.8M |
| Jun 1, 26 | Joseph K BelanoffChief Executive Officer | SELL | 12.8K | $69.74 | $895K |
| May 27, 26 | Joseph Douglas LyonSee Remarks | SELL | 5.0K | $65.00 | $325K |
| May 27, 26 | Sean MaduckSee Remarks | SELL | 54.6K | $66.16 | $3.6M |
| May 5, 26 | William GuyerChief Development Officer | SELL | 20.0K | $51.83 | $1.0M |
| May 1, 26 | Joseph K BelanoffChief Executive Officer | SELL | 40.0K | $50.10 | $2.0M |
| Apr 7, 26 | William GuyerChief Development Officer | SELL | 20.0K | $40.97 | $819K |
| Mar 25, 26 | Joseph K BelanoffChief Executive Officer | SELL | 26.2K | $50.07 | $1.3M |
| Mar 20, 26 | William GuyerChief Development Officer | SELL | 11.8K | $36.01 | $424K |
| Mar 17, 26 | G Leonard Baker JrDirector | BUY | 75.8K | $33.56 | $2.5M |
| Mar 4, 26 | William GuyerChief Development Officer | SELL | 8.2K | $35.99 | $296K |
| Feb 3, 26 | William GuyerChief Development Officer | SELL | 20.0K | $40.87 | $817K |
| Jan 6, 26 | William GuyerChief Development Officer | SELL | 20.0K | $35.18 | $704K |
| Dec 2, 25 | William GuyerChief Development Officer | SELL | 19.4K | $80.88 | $1.5M |
| Dec 1, 25 | Joseph K BelanoffChief Executive Officer | SELL | 40.0K | $79.77 | $3.2M |
| Dec 1, 25 | Joseph Douglas LyonSee Remarks | SELL | 5.0K | $79.53 | $398K |
| Dec 1, 25 | Sean MaduckSee Remarks | SELL | 20.0K | $79.52 | $1.6M |
| Nov 25, 25 | William GuyerChief Development Officer | SELL | 4.5K | $80.90 | $364K |
| Nov 5, 25 | William GuyerChief Development Officer | SELL | 13.2K | $76.28 | $996K |
| Nov 5, 25 | Joseph K BelanoffChief Executive Officer | SELL | 14.4K | $75.98 | $1.1M |
| Nov 3, 25 | Joseph K BelanoffChief Executive Officer | SELL | 11.2K | $74.08 | $831K |
| Nov 3, 25 | Joseph Douglas LyonSee Remarks | SELL | 5.0K | $73.65 | $368K |
| Nov 3, 25 | Sean MaduckSee Remarks | SELL | 20.0K | $73.99 | $1.5M |
| Oct 10, 25 | Daniel N Swisher JrDirector | SELL | 2.2K | $87.54 | $193K |
| Oct 7, 25 | William GuyerChief Development Officer | SELL | 20.0K | $89.94 | $1.8M |
| Oct 1, 25 | Joseph K BelanoffChief Executive Officer | SELL | 31.2K | $85.67 | $2.7M |
| Oct 1, 25 | Joseph Douglas LyonSee Remarks | SELL | 3.5K | $85.39 | $295K |
| Oct 1, 25 | Sean MaduckSee Remarks | SELL | 16.4K | $85.58 | $1.4M |
| Sep 10, 25 | Daniel N Swisher JrDirector | SELL | 2.2K | $72.45 | $159K |
| Sep 2, 25 | Joseph K BelanoffChief Executive Officer | SELL | 39.3K | $71.01 | $2.8M |
| Sep 2, 25 | William GuyerChief Development Officer | SELL | 15.6K | $70.85 | $1.1M |
| Sep 2, 25 | Joseph Douglas LyonSee Remarks | SELL | 4.9K | $70.76 | $344K |
| Sep 2, 25 | Sean MaduckSee Remarks | SELL | 15.1K | $70.84 | $1.1M |
| Aug 22, 25 | Gary Charles RobbChief Business Officer | SELL | 2.3K | $71.27 | $166K |
| Aug 11, 25 | Daniel N Swisher JrDirector | SELL | 2.2K | $72.30 | $159K |
| Aug 8, 25 | William GuyerChief Development Officer | SELL | 35.0K | $71.77 | $2.5M |
| Aug 5, 25 | William GuyerChief Development Officer | SELL | 14 | $71.77 | $1K |
| Aug 1, 25 | Joseph K BelanoffChief Executive Officer | SELL | 17.8K | $69.65 | $1.2M |
| Aug 1, 25 | Joseph Douglas LyonSee Remarks | SELL | 5.8K | $67.51 | $393K |
| Aug 1, 25 | Sean MaduckSee Remarks | SELL | 27.9K | $69.70 | $1.9M |
| Jul 18, 25 | William GuyerChief Development Officer | SELL | 500 | $73.44 | $37K |
Over the past 12 months, insiders at CORCEPT THERAPEUTICS INC filed 2 open-market purchases worth $3.3M and 82 sales worth $69.6M on CORT, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 15, 26.
The largest recent open-market CORT insider purchase in our data was $2.5M by G Leonard Baker Jr, Director, filed on Mar 17, 26.
10 different insiders at CORCEPT THERAPEUTICS INC filed open-market SEC Form 4 transactions on CORT over the last 12 months.
InsiderTape plots every CORT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every CORCEPT THERAPEUTICS INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →